The Croatian Competition Authority issues an opinion concerning the exclusionary effect of a new prescription drugs reimbursement model

Exclusionary effect of the new prescription drugs model* Based on the complaint made by the Croatian Employers’ Association – Pharmaceutical Manufacturers Association, Innovative Medicines Initiative and Generic Drugs Manufacturers Association, the Croatian Competition Agency (CCA) carried out a legal analysis of the Croatian Health Insurance Fund (HZZO) Guide for the new referral model identifying the basic drugs reimbursement list and the criteria for prescribing prescription drugs. Besides the legal analysis of the document in question the CCA also took into account the comparative practice of some EU member states in the area concerned. First, it must be taken into account that this is a highly regulated industry, given the specific nature of the product concerned (medicines),

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Croatian Competition Authority, The Croatian Competition Authority issues an opinion concerning the exclusionary effect of a new prescription drugs reimbursement model, 21 May 2015, e-Competitions Bulletin May 2015, Art. N° 73458

Visites 87

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues